The Novartis Foundation is launching a blood pressure management program in Vietnam as part of its larger effort to combat the rise of chronic diseases in urban areas of developing countries.
Novartis is partnering with the International Committee of the Red Cross (ICRC) to improve care and treatment for Syrian refugees in Lebanon suffering from chronic diseases.
The Novartis Business Development and Licensing team is behind many of the partnerships that fuel our innovation.
Learn how Novartis is working with chronic obstructive pulmonary disease (COPD) patients to develop digital health technologies that help them find their “new normal.”
Novartis and other industry leaders call for action to address antimicrobial resistance, one of the world’s most serious public health challenges
Novartis employs new technologies to cut greenhouse gas emissions, reduce water consumption and non-recyclable waste
Dr. George Vratsanos, rheumatologist and Executive Global Program Head at Novartis Pharmaceuticals, shares his team’s top five principles that are at the heart of our clinical trial program.
We asked patients for their feedback on an upcoming clinical trial in Australia. Here’s what they said.
We are partnering with the Friedrich Miescher Institute on more than 50 research projects to improve and extend people’s lives.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG report.
This site is intended for a global audience.